| 000 | 01553 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518073145.0 | ||
| 264 | 0 | _c20200508 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v25.i44.6551 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Ying | |
| 245 | 0 | 0 |
_aReal life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cNov 2019 |
||
| 300 |
_a6551-6560 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 700 | 1 | _aWu, Feng-Ping | |
| 700 | 1 | _aWang, Wen-Jun | |
| 700 | 1 | _aShi, Juan-Juan | |
| 700 | 1 | _aLi, Ya-Ping | |
| 700 | 1 | _aZhang, Xin | |
| 700 | 1 | _aDang, Shuang-Suo | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 25 _gno. 44 _gp. 6551-6560 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v25.i44.6551 _zAvailable from publisher's website |
| 999 |
_c30386955 _d30386955 |
||